BridgeMD
New treatment option for Halitosis
Official title Comparative Study Between Photodynamic Therapy with LED Associated with Probiotics in the Treatment of Halitosis
ClinicalTrials.gov ID: NCT06583720
What this study is testing
- What it's testing
- Halitosis is a term that defines any odor or bad smell coming from the oral cavity, which can have a local or systemic origin. This project aims to verify if there is a difference in the effectiveness of treatment with antimicrobial photodynamic therapy (aPDT) with LED associated with treatment using probiotics in reducing halitosis.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Diagnosis of halitosis showing sulfhydride (SH2) ≥ 112 ppb in gas chromatography.
You likely can't join if
- Individuals with dentofacial anomalies (such as cleft lip, cleft palate and nasopalatine);
- Undergoing orthodontic and/or orthopedic treatment;
- Undergoing oncological treatment;
- With systemic alterations (gastrointestinal, renal, hepatic)
- Undergoing antibiotic treatment up to 1 month before the research;
- Pregnant women.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.